Registry of X-linked Adrenoleukodystrophy

Status Recruiting

Clinical Trial Summary

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Clinical Trial Description

In this study, X-ALD patients will be selected as study participants. Through a longitudinal collection of genetic, imaging and clinical symptoms data of the patients and carriers. The purpose of this study is to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients. Through the long-term follow-up of imaging and clinical symptoms progress and outcome of X-ALD patients, combined with genetic data, we will improve the relationships between genes and phenotypes, and explore the deep insight in the pathophysiological mechanism of X-ALD, to provide a theoretical basis for the treatment and management of X-ALD patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05939232
Study type	Observational [Patient Registry]
Source	Beijing Tiantan Hospital
Contact	Yilong Wang, MD, PhD
Phone	0086-010-67092222
Email	yilong528@aliyun.com
Status	Recruiting
Phase
Start date	July 20, 2023
Completion date	December 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05911919` - Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy
Recruiting	`NCT03727555` - Lentiviral Gene Therapy for X-ALD	N/A
Completed	`NCT02595489` - A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy	Phase 1
Completed	`NCT01594853` - Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy	N/A
Completed	`NCT04687007` - SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)	N/A
Completed	`NCT01165060` - The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)	N/A
Active, not recruiting	`NCT02699190` - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Completed	`NCT03864523` - Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy	Phase 2
Recruiting	`NCT06178120` - Disease Progression in Women With X-linked Adrenoleukodystrophy
Recruiting	`NCT03278899` - A Study to Prospectively Assess Disease Progression in Male Children With X-ALD
Recruiting	`NCT03047369` - The Myelin Disorders Biorepository Project
Recruiting	`NCT04675749` - Quality of Life in Women With X-linked Adrenoleukodystrophy
Withdrawn	`NCT03196765` - Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy	Phase 1/Phase 2
Withdrawn	`NCT01787578` - Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)	Phase 1
No longer available	`NCT02233257` - Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy	N/A